knowledge -WSS

knowledge

author：hotspot 2025-10-01 22:57:29 - browse：27688

Scientist Nour Tabidi prepares a DNA sample in a lab. -- health coverage from STAT — Scientist Nour Tabidi prepares a DNA sample in a lab at Thermo Fisher's recently opened manufacturing plant in Plainville. John Tlumacki/Globe Staff

Thermo Fisher Scientific’s giant plant to manufacture gene therapies for drug companies is barely a year old, but executives at the maker of scientific tools are already talking about expanding.

Standing inside a cavernous unfinished section of the plant, Paul Fitzgerald, vice president and general manager of the site, told a group of biotech executives, journalists, and other visitors that he’s eager to transform it into laboratories. So far, the company is only using about 290,000 of the plant’s more than 400,000 square feet.

“I look forward to you guys giving us a reason to fill up this space,” Fitzgerald quipped during a tour Tuesday of the plant.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： BioMarin wins approval for gene therapy to treat hemophilia A
Next article： Resistance to opioid

focus

WSS

Resistance to opioid

Sick patients collapsed waiting for care at Massachusetts hospital with known safety violations

Why we need to separate burnout from moral injury in health care

In areas with more Black doctors, Black people live longer

With FDA staff opposed to Sarepta therapy, top official intervened

Donald Trump's relentless attacks on special counsel Jack Smith

entertainment

knowledge

Wikipedia

Hepatitis C has a cure — but many Americans still lack access to it

With FDA staff opposed to Sarepta therapy, top official intervened

Malaria cases in Florida and Texas: Here’s what you need to know

ACIP vaccine advisory panel sees its vacancies filled

Novavax promises a turnaround & Lilly roils the obesity market

CDC concerned about possible undetected monkeypox spread in U.K.

Psychedelics group wrestles with new pharma identity

Study: Lilly Alzheimer's therapy slowed patients' cognitive decline

DIEP, the 'gold standard' of breast reconstruction, is under threat

#NeedHerScience: shining a light on gender disparities in medicine

explore

Eli Lilly reports tirzepatide MASH success during Q4 earnings

Donald Trump's relentless attacks on special counsel Jack Smith

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

Report cites 'urgent' need to recruit more diverse clinical trial participants

Ask STAT: What do you want to know about ChatGPT in medicine?

AMAs digital advisors table RPM coding reform proposal, again

entertainment

focus

Wikipedia

hotspot